- Home
- Patient & Visitors
- Research & Clinical Trials
- Find Clinical Trials
Find Clinical Trials
Current Clinical Trials
Breast
Disease Site | Title | Status |
---|---|---|
Breast |
Pembrolizumab in Treating Patients with Triple-Negative Breast Cancer Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Breast |
A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Breast |
Aspirin in Preventing Recurrence of Cancer in Patients with Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Breast |
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant (BYLieve) Principal Investigator: Ike Onwere, MD |
Click here for more information on this trial. |
Breast |
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Breast |
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Principal Investigator: Michael Wahl, MD |
Click here for more information on this trial. |
Lung
Disease Site | Title | Status |
---|---|---|
Lung |
Genetic Testing in Screening Patients with Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Lung |
Crizotinib in Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Lung |
Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Lung |
Nivolumab After Surgery and Chemotherapy in Treating Patients with Stage IB-IIIA Non-Small Cell Lung Cancer (ANVIL) Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Lung |
Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer Principal Investigator: Michael Wahl, MD |
Click here for more information on this trial. |
Lung |
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Other
Disease Site | Title | Status |
---|---|---|
Prostate Registry (Not a treatment trial) |
Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) (TRUMPET) Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Advanced Cancers |
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma Principal Investigator: Wei Bai, MD |
Click here for more information on this trial. |
Colon |
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Bladder |
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer Principal Investigator: David Hufnagel, DO |
Click here for more information on this trial. |
Myelofibrosis and Essential Thrombocythemia |
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST) Principal Investigator: Ike Onwere, MD |
Click here for more information on this trial. |
To learn more about cancer clinical trials available, visit clinicaltrials.gov.
Disease Site | Title | Status |
---|---|---|
Patients with certain kinds of Pacemakers | MultiPoint Pacing™ Post Market Study (MPP-PMS) |
Click here for more information on this trial. |
Patients with Heart Failure, but Preserved Ejection Fraction |
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients (PARALLAX)
Principal Investigator: Sridhar Vijayasekaran, MD |
Click here for more information on this trial. |
Patients with a New Index Myocardial Infarction (MI) |
Prospective ARNI vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI (PARADISE-MI)
Principal Investigator: Edward Toggart, MD |
Click here for more information on this trial. |
Device Study Looking for Patients Who Have a Current Generation Pacemaker Device Who Are in Need of an MRI |
SJM MRI Diagnostic Imaging Registry (IDE)
Principal Investigator: Jeff Hsing, MD |
Click here for more information on this trial. |
PUMA-NER-6201: A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide |
PUMA-NER-6201: A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and L |
Disease Site | Title | Status |
---|---|---|
Invasive Fungal Infections Registry (Not a treatment trial) |
Observational Disease Registry of Patients Treated with Systemic Mold-Active Triazoles Principal Investigator: Sugat Patel, MD |
Click here to learn more about this trial. |
Condition | Title | Status |
---|---|---|
Insulin Sensitivity, Obesity and Sedentary Lifestyle |
Exercise and Insulin Signaling in Human Skeletal Muscle
|
Click here for more information on this trial or review an informational flyer. |
Cardiac registry for student athletes | Cardiovascular Screening in the Pac-12 Conference: Establishing Best Practices | Click here for more information on this trial. |
For more information about clinical research at Samaritan, call 541-768-4352.